New issues for scrutiny include: Ophthalmological Services–Questionable Billing; Modifiers GA/GZ/GY and appropriate use; Onsite Visits for Medicare Provider and Supplier Enrollment and Reenrollment; Hospitals–Acquisitions of Ambulatory Surgical Centers; and Impact on Medicare Spending. QIs the OIG still ...